ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.67
0.00%
US Tech 100
19,131.60
-0.23%
S&P 500
5,477.90
0.16%
US Dollar vs CAD
1.36998
-0.04%
Bitcoin
61,033.58
0.36%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Maia Biotechnology Inc (MAIA)

  7. Maia Biotechnology Inc (MAIA) News

MAIA

Maia Biotechnology (MAIA)

Maia Biotechnology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:MAIA
DateTimeSourceHeadlineSymbolCompany
06/07/202411:31AMBusiness WireMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent TherapyAMEX:MAIAMaia Biotechnology Inc
06/06/20241:57PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
06/06/20249:07AMBusiness WireMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer AgentAMEX:MAIAMaia Biotechnology Inc
06/04/20243:06PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
06/04/20247:41AMBusiness WireMAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung CancerAMEX:MAIAMaia Biotechnology Inc
06/03/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/29/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/17/20247:37AMBusiness WireMAIA Biotechnology to Present at the BIO International Convention 2024AMEX:MAIAMaia Biotechnology Inc
05/16/20247:37AMBusiness WireMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingAMEX:MAIAMaia Biotechnology Inc
05/15/20243:07PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
05/15/20243:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:MAIAMaia Biotechnology Inc
05/14/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:MAIAMaia Biotechnology Inc
05/07/20244:21PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
04/30/20247:08AMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
04/29/20247:08AMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementAMEX:MAIAMaia Biotechnology Inc
04/23/20247:51AMBusiness WireMAIA Biotechnology Announces $1.00 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
04/05/20247:01AMBusiness WireMAIA Biotechnology to Present at Two Investor Conferences in April 2024AMEX:MAIAMaia Biotechnology Inc
03/28/20242:00PMBusiness WireMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroAMEX:MAIAMaia Biotechnology Inc
03/26/20242:00PMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementAMEX:MAIAMaia Biotechnology Inc
03/26/20247:01AMBusiness WireMAIA Biotechnology Announces $1.33 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
03/22/20242:00PMBusiness WireMAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private PlacementAMEX:MAIAMaia Biotechnology Inc
03/21/20242:00PMBusiness WireMAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory BoardAMEX:MAIAMaia Biotechnology Inc
03/08/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
03/07/20248:45AMBusiness WireMAIA Biotechnology to Participate in the 36th Annual ROTH ConferenceAMEX:MAIAMaia Biotechnology Inc
03/06/202410:04AMBusiness WireMAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual MeetingAMEX:MAIAMaia Biotechnology Inc
03/06/20247:48AMBusiness WireMAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer PatientsAMEX:MAIAMaia Biotechnology Inc
03/06/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
03/05/20247:45AMBusiness WireMAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to ShareholdersAMEX:MAIAMaia Biotechnology Inc
02/27/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
02/23/20243:17PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:MAIAMaia Biotechnology Inc
 Showing the most relevant articles for your search:AMEX:MAIA

Your Recent History

USOTC
DPUI
Discount Print USA (PK)
USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
CYDY
CytoDyn (QB)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
UEEC
United Health Products (PK)
NASDAQ
FFIE
Faraday Future Intellige...
USOTC
ECSL
Ecare Solutions (PK)
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
AMRN
Amarin
USOTC
BLEG
Branded Legacy (PK)
USOTC
SAPX
Seven Arts Entertainment (PK)
NASDAQ
NB
NioCorp Developments
USOTC
RDGL
Vivos (QB)
USOTC
WDLF
Decentral Life (PK)
USOTC
AFFU
Affluence (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved